HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hui Zhi Selected Research

Adenocarcinoma of Lung

1/2022Epigenome signature as an immunophenotype indicator prompts durable clinical immunotherapy benefits in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hui Zhi Research Topics

Disease

24Neoplasms (Cancer)
01/2022 - 03/2012
4Fibrosis (Cirrhosis)
01/2022 - 08/2011
3Breast Neoplasms (Breast Cancer)
01/2022 - 09/2014
3Neoplasm Metastasis (Metastasis)
01/2021 - 02/2007
3Colorectal Neoplasms (Colorectal Cancer)
10/2020 - 10/2016
3Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 07/2011
3Type 2 Diabetes Mellitus (MODY)
11/2014 - 11/2012
3Hypogonadism (Hypergonadotropic Hypogonadism)
05/2012 - 03/2008
2Pathologic Processes
12/2021 - 01/2015
2Cognitive Dysfunction
01/2021 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2021 - 08/2013
2Hypertension (High Blood Pressure)
04/2019 - 08/2011
2Lyme Disease (Disease, Lyme)
01/2019 - 04/2015
2Carcinoma (Carcinomatosis)
01/2018 - 02/2007
2Constipation
08/2013 - 06/2011
2Hypoxia (Hypoxemia)
07/2013 - 07/2011
2Inflammation (Inflammations)
08/2011 - 07/2011
1Communicable Diseases (Infectious Diseases)
12/2022
1Autism Spectrum Disorder
03/2022
1Adenocarcinoma of Lung
01/2022
1Hydronephrosis
01/2022
1Non-alcoholic Fatty Liver Disease
11/2021
1COVID-19
09/2021
1Bacterial Infections (Bacterial Infection)
01/2021
1Fatigue
01/2021
1Alopecia (Baldness)
01/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
01/2021
1Hyperpigmentation
01/2021
1Thyroid Diseases (Thyroid Disease)
02/2019
1Atherosclerosis
11/2018
1Infections
01/2018
1Carcinogenesis
07/2016
1Autistic Disorder (Autism)
01/2016
1Angelman Syndrome (Syndrome, Angelman)
01/2016

Drug/Important Bio-Agent (IBA)

15Long Noncoding RNAIBA
01/2022 - 07/2014
8MicroRNAs (MicroRNA)IBA
01/2022 - 03/2012
7Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2017
6Competitive Endogenous RNAIBA
01/2022 - 07/2016
4Messenger RNA (mRNA)IBA
01/2022 - 02/2007
4Biological ProductsIBA
01/2021 - 01/2015
4Pharmaceutical PreparationsIBA
01/2019 - 03/2012
3Transcription Factors (Transcription Factor)IBA
01/2021 - 07/2016
3RNA (Ribonucleic Acid)IBA
01/2021 - 07/2014
3Complement System Proteins (Complement)IBA
01/2020 - 01/2018
3rGLP-1 proteinIBA
11/2014 - 11/2012
3Testosterone (Sustanon)FDA Link
05/2012 - 03/2008
2Circular RNAIBA
01/2021 - 01/2019
2Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 10/2016
2Persistent Organic PollutantsIBA
01/2019 - 11/2018
2Proteins (Proteins, Gene)FDA Link
01/2016 - 04/2015
2Glucagon-Like Peptide 1 (GLP 1)IBA
11/2014 - 11/2012
2Angiotensin IIIBA
08/2011 - 07/2011
2Dutasteride (Avodart)FDA Link
02/2011 - 03/2008
1Nucleic AcidsIBA
12/2022
1Extracellular Matrix ProteinsIBA
01/2022
1Calcibiotic Root Canal SealerIBA
01/2022
1ChromatinIBA
01/2022
1isopentenyl methylenediphosphonateIBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1EnzymesIBA
01/2022
1Tissue Inhibitor of Metalloproteinase-2IBA
01/2022
1Cathepsin BIBA
11/2021
1InflammasomesIBA
11/2021
1NLR ProteinsIBA
11/2021
1Methionine (L-Methionine)FDA Link
11/2021
1Choline (Choline Chloride)IBA
11/2021
1carfilzomibIBA
09/2021
1ixazomibIBA
09/2021
1Citric Acid (Citrate)FDA LinkGeneric
09/2021
1Antiviral Agents (Antivirals)IBA
09/2021
1Bortezomib (Velcade)FDA Link
09/2021
1Proteasome InhibitorsIBA
09/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1AnthracyclinesIBA
01/2021
1Small Cytoplasmic RNAIBA
01/2021
1Taxoids (Taxanes)IBA
01/2021
1CytokinesIBA
01/2021
1DiterpenesIBA
01/2021
1AntigensIBA
01/2020
1Brain-Derived Neurotrophic Factor (BDNF)IBA
07/2019
1erucylphosphocholineIBA
04/2019
1NAD (NADH)IBA
04/2019
1AutoantibodiesIBA
02/2019
1decabromobiphenyl ether (decabromodiphenyl ether)IBA
11/2018
1oxidized low density lipoproteinIBA
11/2018
1TamoxifenFDA LinkGeneric
01/2018
1Immunoglobulin M (IgM)IBA
01/2018
1Immunoglobulin G (IgG)IBA
01/2018
1AntibodiesIBA
01/2018
1Trastuzumab (Herceptin)FDA Link
05/2016
1Contrast MediaIBA
05/2016
1Phospholipids (Phosphatides)FDA LinkGeneric
05/2016
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
01/2016
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2016

Therapy/Procedure

6Therapeutics
01/2022 - 03/2008
4Drug Therapy (Chemotherapy)
01/2022 - 09/2014
2Immunotherapy
01/2022 - 01/2021
1Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2022
1Acupuncture Therapy
01/2021
1Acupuncture Points (Acupuncture Point)
01/2021